Capricor Therapeutics (CAPR) Free Cash Flow Growth (3y) (2013 - 2026)
Capricor Therapeutics (CAPR) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
-121.72% |
| Date | Value |
|---|
| Mar 31, 2026 |
-121.72% |
| Dec 31, 2025 |
-49.21% |
| Sep 30, 2025 |
-46.78% |
| Jun 30, 2025 |
-44.80% |
| Mar 31, 2025 |
-32.23% |
| Dec 31, 2024 |
-36.60% |
| Sep 30, 2024 |
-45.20% |
| Jun 30, 2024 |
-36.67% |
| Mar 31, 2024 |
17.69% |
| Dec 31, 2023 |
-43.29% |
| Sep 30, 2023 |
-42.54% |
| Jun 30, 2023 |
-65.07% |
| Mar 31, 2023 |
72.92% |
| Dec 31, 2022 |
-62.05% |
| Sep 30, 2022 |
-55.78% |
| Jun 30, 2022 |
-55.81% |
| Mar 31, 2022 |
155.12% |
| Dec 31, 2021 |
-16.88% |
| Sep 30, 2021 |
-6.77% |
| Jun 30, 2021 |
-9.42% |
